Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Naveed A. Wagle, MD

    TitleAssistant Professor of Clinical Neurology
    SchoolKeck School of Medicine of USC
    AddressNTT 3440
    Health Sciences Campus
    Los Angeles California 90089-9173
    Phone+1 323 442 9473
    vCardDownload vCard
      Other Positions
      TitleAcgme Program Director

      Collapse Overview 
      Collapse Overview
      Dr. Wagle’s specialized training and research in the treatment of cancer of the central and peripheral nervous system make him an invaluable resource to the University and the community. He brings expertise in neuro-oncologic clinical trial design and implementation. In his new role, Dr. Wagle will treat patients with primary and metastatic brain tumors as well as neurologic complications of cancer at the university–owned Keck Hospital of USC and USC Norris Comprehensive Cancer Center and Hospital.

      Dr. Wagle is a Diplomate of the American Board of Psychiatry and Neurology as well as the National Board of Medical Examiners. He is an active member of the Society for Neuro-Oncology, the American Association for Cancer Research, the American Society of Clinical Oncology, the American Academy of Neurology and the American Medical Association.

      Collapse Biography 
      Collapse Clinical Trials
      Collapse Awards and Honors
      Chicago Medical School Outstanding Research Award2005John J. Shenin Award
      Chicago Medical School2005Medical Student Clerkship Excellence in Neurology
      American Federation of Aging Research2002John A. Hartford Scholar
      Chicago Medical School2001  - 2002Honor Council Member
      University of Southern California1995  - 1999Dean's List

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Moazzam AA, Wagle N, Shiroishi MS. Malignant transformation of DNETs: a case report and literature review. Neuroreport. 2014 Aug 20; 25(12):894-9. PMID: 25003949.
        View in: PubMed
      2. Sivasundaram L, Hazany S, Wagle N, Zada G, Chen TC, Lerner A, Go JL, D'Amore F, Law M, Shiroishi MS. Diffusion restriction in a non-enhancing metastatic brain tumor treated with bevacizumab - recurrent tumor or atypical necrosis? Clin Imaging. 2014 Sep-Oct; 38(5):724-6. PMID: 24910165.
        View in: PubMed
      3. Liu SV, Wagle N, Zada G, Sun B, Go J, Rashtian A. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma. Head Neck. 2013 Nov; 35(11):E343-5. PMID: 23471826.
        View in: PubMed
      4. Standley S, Tocco G, Wagle N, Baudry M. High- and low-affinity alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits. J Neurochem. 1998 Jun; 70(6):2434-45. PMID: 9603208.
        View in: PubMed
      5. Standley S, Wagle N, Baudry M. Developmental changes in subcellular AMPA/GluR receptor populations in rat forebrain. Brain Res Dev Brain Res. 1998 May 15; 107(2):277-83. PMID: 9593938.
        View in: PubMed